KCL 2015

Dr Augustin talks about her involvement in one of the UK's first successfully crowdfunded clinical trials - using public support to repurpose artesunate, an antimalarial drug, to treat patients with bowel cancer.

Dr Pantziarka discusses the risks associated with Li Fraumeni Syndrome, the complex issues which surround the diagnosis and management of the disease and the pharmacological interventions which have the potential to reduce the cancer risk in individuals with Li Fraumeni Syndrome.

Dr Watkins discusses the first study to systematically explore the consequences that changes in unemployment have had in generating excess deaths due to prostate cancer. He talks about the wide variety of variables involved and how doctors can use the knowledge generated by the study to change their clinical practice, as well as the implications for policy.